ATE448788T1 - Behandlung von entzündlichen darmerkrankungen mit 2-methylen-19-nor-vitamin d verbindungen - Google Patents
Behandlung von entzündlichen darmerkrankungen mit 2-methylen-19-nor-vitamin d verbindungenInfo
- Publication number
- ATE448788T1 ATE448788T1 AT04778892T AT04778892T ATE448788T1 AT E448788 T1 ATE448788 T1 AT E448788T1 AT 04778892 T AT04778892 T AT 04778892T AT 04778892 T AT04778892 T AT 04778892T AT E448788 T1 ATE448788 T1 AT E448788T1
- Authority
- AT
- Austria
- Prior art keywords
- methylene
- vitamin
- inflammatory bowel
- bowel disease
- compounds
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/59—Compounds containing 9, 10- seco- cyclopenta[a]hydrophenanthrene ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
Landscapes
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Rheumatology (AREA)
- Pain & Pain Management (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US10/680,881 US7704980B2 (en) | 2003-10-08 | 2003-10-08 | Treatment of inflammatory bowel disease with 2-methylene-19-nor-vitamin D compounds |
PCT/US2004/023586 WO2005039592A1 (en) | 2003-10-08 | 2004-07-23 | Treatment of inflammatory bowel disease with 2-methylene-19-nor-vitamin d compounds |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE448788T1 true ATE448788T1 (de) | 2009-12-15 |
Family
ID=34422197
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT04778892T ATE448788T1 (de) | 2003-10-08 | 2004-07-23 | Behandlung von entzündlichen darmerkrankungen mit 2-methylen-19-nor-vitamin d verbindungen |
Country Status (10)
Country | Link |
---|---|
US (2) | US7704980B2 (de) |
EP (1) | EP1673095B1 (de) |
JP (1) | JP2007508298A (de) |
AT (1) | ATE448788T1 (de) |
AU (1) | AU2004283073B2 (de) |
CA (1) | CA2541991A1 (de) |
DE (1) | DE602004024221D1 (de) |
ES (1) | ES2338428T3 (de) |
NZ (1) | NZ546440A (de) |
WO (1) | WO2005039592A1 (de) |
Families Citing this family (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA2764577C (en) * | 2009-08-03 | 2017-12-19 | Wisconsin Alumni Research Foundation | Method of preventing renal disease and treating symptoms thereof |
US8604009B2 (en) * | 2010-03-23 | 2013-12-10 | Wisconsin Alumni Research Foundation | (20S)-2-methylene-19-nor-22-dimethyl-1α,25-dihydroxyvitamin D3 and (20R)-2-methylene-19-nor-22-dimethyl-1α,25-hydroxyvitamin D3 |
AU2011232562B2 (en) * | 2010-03-23 | 2014-10-02 | Wisconsin Alumni Research Foundation | Diastereomers of 2-methylene-19-nor-22-methyl-1alpha,25- dihydroxyvitamin D3 |
US8664206B2 (en) | 2010-03-23 | 2014-03-04 | Wisconsin Alumni Research Foundation | Diastereomers of 2-methylene-19-nor-22-methyl-1α,25-dihydroxyvitamin D3 |
FR2961401B1 (fr) * | 2010-06-17 | 2013-04-05 | Laetitia Mathez | Composition anti-inflammatoire |
CN102631354B (zh) * | 2011-02-11 | 2015-01-21 | 广东泰禾医药科技有限公司 | 含维生素d3和二甲双胍的药物组合物 |
JP6059716B2 (ja) | 2011-06-03 | 2017-01-11 | ウイスコンシン アラムニ リサーチ ファンデーション | (22E)−2−メチレン−26,27−シクロ−22−デヒドロ−1α−ヒドロキシ−19−ノルビタミンD3誘導体 |
US20130295083A1 (en) * | 2012-05-02 | 2013-11-07 | Wisconsin Alumni Research Foundation | 2a-Methyl-19-nor-(20S)-1a,25-dihydroxyvitamin D3 (2AMD) or 2 methylene-19-nor-(20S)-1a,25-dihydroxyvitamin D3 (2MD) Support Survival and Function of Transplanted Islet Cells In Type 1 Diabetes |
AU2013281217B2 (en) | 2012-06-29 | 2017-03-02 | Wisconsin Alumni Research Foundation | Use of 2-methylene-19-nor-(20S)-1alpha,25-dihydroxyvitamin D3 to treat secondary hyperparathyroidism |
US9370527B2 (en) | 2012-12-28 | 2016-06-21 | The Regents Of The University Of Michigan | Amelioration of intestinal fibrosis and treatment of Crohn's disease |
US10369161B2 (en) | 2014-12-30 | 2019-08-06 | Wisconsin Alumni Research Foundation | Use of 2-methylene-19-NOR-(20S)-1-alpha,25-dihydroxyvitamin D3 to treat primary hyperparathyroidism |
US9539264B2 (en) | 2014-12-30 | 2017-01-10 | Wisconsin Alumni Research Foundation | Use of 2-methylene-19-nor-(20S)-1-alpha,25-dihydroxyvitamin D3 to treat secondary hyperparathyroidism in patients previously treated with calcimimetics |
US20170296558A1 (en) * | 2016-04-18 | 2017-10-19 | Wisconsin Alumni Research Foundation | Use of 2amd and 2md to treat fibrosis |
Family Cites Families (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE4221961A1 (de) | 1992-06-30 | 1994-01-05 | Schering Ag | 22-En-25-oxa-Derivate in der Vitamin D-Reihe, Verfahren zu ihrer Herstellung, diese Derivate enthaltenen pharmazeutische Präparate sowie deren Verwendung als Arzneimittel |
IL107185A (en) | 1992-10-06 | 1998-02-22 | Schering Ag | History of 52-carboxylic acid, processes for their preparation and pharmaceutical preparations containing them |
US5981597A (en) * | 1995-02-13 | 1999-11-09 | Trustees Of The University Of Pennsylvania | Differentiating agents for the treatment of inflammatory intestinal diseases |
US5843928A (en) * | 1997-03-17 | 1998-12-01 | Wisconsin Alumni Research Foundation | 2-alkylidene-19-nor-vitamin D compounds |
US6392071B1 (en) * | 1997-03-17 | 2002-05-21 | Wisconsin Alumni: Research Foundation | 26,27-homologated-20-EPI-2-alkylidene-19-nor-vitamin D compounds |
US6989377B2 (en) * | 1999-12-21 | 2006-01-24 | Wisconsin Alumni Research Foundation | Treating vitamin D responsive diseases |
US6358939B1 (en) * | 1999-12-21 | 2002-03-19 | Northern Lights Pharmaceuticals, Llc | Use of biologically active vitamin D compounds for the prevention and treatment of inflammatory bowel disease |
EP1286962B1 (de) * | 2000-05-31 | 2008-06-25 | Wisconsin Alumni Research Foundation | 2-ethyl und 2-ethyliden-19-nor-vitamin d-verbindungen |
BR0113703A (pt) * | 2000-09-08 | 2003-07-22 | Wisconsin Alumni Researcg Foun | Compostos e métodos de tratamento de psorìase, leucemia, câncer do cólon, do seio ou da próstata, osteodistrofia renal, de doenças auto-imune, inflamatória e de condição de pele |
NZ533424A (en) * | 2001-12-13 | 2006-08-31 | Wisconsin Alumni Res Found | Vitamin D derivative, methods of purifying and uses in treating psoriasis, cancer, autoimmune diseases, inflammatory diseases, skin conidtions and renal ostepdystrophy |
US6566352B1 (en) * | 2002-02-18 | 2003-05-20 | Wisconsin Alumni Research Foudation | 1 α-hydroxy-2-methylene-19-nor-pregnacalciferol and its uses |
US7259143B2 (en) * | 2002-09-05 | 2007-08-21 | Wisconsin Alumni Research Foundation | Method of extending the dose range of vitamin D compounds |
-
2003
- 2003-10-08 US US10/680,881 patent/US7704980B2/en not_active Expired - Fee Related
-
2004
- 2004-07-23 JP JP2006533831A patent/JP2007508298A/ja not_active Ceased
- 2004-07-23 DE DE602004024221T patent/DE602004024221D1/de not_active Expired - Lifetime
- 2004-07-23 ES ES04778892T patent/ES2338428T3/es not_active Expired - Lifetime
- 2004-07-23 WO PCT/US2004/023586 patent/WO2005039592A1/en active Application Filing
- 2004-07-23 CA CA002541991A patent/CA2541991A1/en not_active Abandoned
- 2004-07-23 AU AU2004283073A patent/AU2004283073B2/en not_active Expired
- 2004-07-23 AT AT04778892T patent/ATE448788T1/de not_active IP Right Cessation
- 2004-07-23 NZ NZ546440A patent/NZ546440A/xx unknown
- 2004-07-23 EP EP04778892A patent/EP1673095B1/de not_active Expired - Lifetime
-
2010
- 2010-02-17 US US12/707,358 patent/US20100160267A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
US20100160267A1 (en) | 2010-06-24 |
DE602004024221D1 (de) | 2009-12-31 |
EP1673095A1 (de) | 2006-06-28 |
AU2004283073B2 (en) | 2010-05-27 |
NZ546440A (en) | 2009-08-28 |
US7704980B2 (en) | 2010-04-27 |
US20050080059A1 (en) | 2005-04-14 |
EP1673095B1 (de) | 2009-11-18 |
WO2005039592A1 (en) | 2005-05-06 |
AU2004283073A1 (en) | 2005-05-06 |
ES2338428T3 (es) | 2010-05-07 |
CA2541991A1 (en) | 2005-05-06 |
JP2007508298A (ja) | 2007-04-05 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATE448788T1 (de) | Behandlung von entzündlichen darmerkrankungen mit 2-methylen-19-nor-vitamin d verbindungen | |
GB0223038D0 (en) | Therapeutic compounds | |
ATE355852T1 (de) | Verwendung von botulinum toxin zur behandlung von herz- und kreislaufskrankheiten | |
NO20014842L (no) | Docetaksel i kombinasjon med rhuMAb HER2 for behandling av kreft | |
SE8903914D0 (sv) | Oral composition for the treatment of inflammatory bowel diseases | |
NO20061325L (no) | Kombinasjon av legemidler for behandling av neoplasmer | |
ATE281839T1 (de) | Behandlung des kongestiven herzversagens durch vorbehandeltes autologes blut | |
CY1108629T1 (el) | Συνδυασμος ετ 743 με 5 φθοριοουρακιλο προ-φαρμακα δια την θεραπευτικη αγωγη του καρκικου | |
CY1109191T1 (el) | Μια νεα χρηση της δεφεριπρονης | |
BRPI0517976A (pt) | métodos de tratamento | |
DE60144514D1 (de) | Verwendung von il-18 inhibitoren | |
DE60327557D1 (de) | Verwendung von spongosin (2-methoxyadenosin) zur behandlung von schmerzen, insbesondere hyperalgesie | |
DE60017801D1 (de) | Inhalierung von antiendotoxinmitteln zur vorbeugung oder behandlung von bakterieller lungeninfektion oder symptomatischer endotoxinaussetzung der lunge | |
DK1646328T3 (da) | Behandling af afhængighedsophör | |
ATE536178T1 (de) | Therapeutische anwendung von methionin zur behandlung oder prävention von mucositis | |
EA200801731A1 (ru) | Составы и способы лечения тробмоцитемии | |
BR0015039A (pt) | Método para administrar um inibidor fosfodiesterase 4 | |
ATE447426T1 (de) | Elektromagnetische stimulation bei patienten mit osteoporose | |
RU2006113366A (ru) | Терапевтическое лечение | |
BRPI0409699A (pt) | métodos de indução do efeito diurético, de indução, manutenção ou restauração do efeito diurético de diurético não modificador de adenosina, de manutenção, restauração ou melhoria da função renal em paciente, de indução de diurese, de prevenção do inìcio de deficiência renal em paciente com sobrecarga de fluidos ou chf, de tratamento de paciente que sofre de chf e de melhoria dos resultados globais da saúde, composição farmacêutica e seus usos | |
DE60229240D1 (de) | Verwendung eines analoges des vitamins d3 zur behandlung des autoimmunen diabetes | |
DE60206280D1 (de) | Verwendung von extrakten aus ginkgo biloba zur herstellung eines medikaments zur behandlung von sarcopenia | |
HUP0203486A2 (hu) | Véralvadással összefüggő betegségek megelőzése és kezelése | |
WO2001042205A3 (en) | Treatment of inflammatory bowel disease with vitamin d compounds | |
AU2003283227A8 (en) | Method and means for the treatment of vascular and cardiac diseases |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |